1. Home
  2. LGIH vs HELP Comparison

LGIH vs HELP Comparison

Compare LGIH & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

N/A

Current Price

$40.98

Market Cap

967.4M

ML Signal

N/A

Logo Cybin Inc. Common Stock

HELP

Cybin Inc. Common Stock

N/A

Current Price

$8.80

Market Cap

862.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LGIH
HELP
Founded
2003
2019
Country
United States
Canada
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
967.4M
862.2M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
LGIH
HELP
Price
$40.98
$8.80
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $41.56
AVG Volume (30 Days)
378.0K
★ 1.4M
Earning Date
11-03-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 2.31
N/A
Revenue
★ $1,705,504,000.00
N/A
Revenue This Year
$6.07
N/A
Revenue Next Year
$0.89
N/A
P/E Ratio
$18.52
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$33.55
$3.76
52 Week High
$66.25
$15.15

Technical Indicators

Market Signals
Indicator
LGIH
HELP
Relative Strength Index (RSI) 42.11 38.50
Support Level $39.20 $8.20
Resistance Level $41.50 $11.74
Average True Range (ATR) 2.66 0.82
MACD 0.01 -0.03
Stochastic Oscillator 8.64 20.00

Price Performance

Historical Comparison
LGIH
HELP

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Share on Social Networks: